The glaucoma specialist and researcher from Glaucoma Center of San Francisco is also a medical editor for the Gleams newsletter published by Glaucoma Research Foundation and lecturer at the annual Glaucoma 360 Symposium in San Francisco.
The annual Glaucoma 360 Gala at the Grand Hyatt San Francisco honored leaders in glaucoma research innovation and visionary glaucoma advocates helping to raise awareness.
GRF annual glaucoma research grants will support 12 investigators at prestigious colleges and universities across the United States.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
The three-day event highlights innovation in glaucoma therapies to ensure patients have access to the latest and most effective diagnostic tools and treatment options.
Ophthalmology industry innovators Vicente Anido, Jr., PhD and Thomas A. Mitro of Aerie Pharmaceuticals, Inc. will be honored at the Glaucoma 360 Annual Gala on February 6, 2020 in San Francisco.
Preliminary applications for one-year Shaffer Grants in the amount of $50,000 are being accepted until July 15, 2019 through the Glaucoma Research Foundation website.
Nancy and Pat Forster chaired Glaucoma Research Foundation’s 2019 Annual Glaucoma 360 Gala, raising a record $660,000 to advance glaucoma research and education programs.
The Catalyst for a Cure Vision Restoration Initiative builds on 16 years of seminal scientific research, with an aim to cure glaucoma and restore vision.
The announcement during World Glaucoma Week emphasizes the need to find a cure for this disease that affects more than 60 million people worldwide.
For her research project seeking a new treatment to restore vision in glaucoma patients, Adriana Di Polo, PhD, professor of neuroscience at the University of Montreal, was awarded the 2019 Shaffer Prize for Innovative Glaucoma Research. The 2019 Shaffer Prize was presented on January 31st during ceremonies at the Glaucoma 360 Annual Gala at the Palace Hotel in San Francisco.
Glaucoma is a group of eye diseases that gradually steal sight without warning. Although the most common forms primarily affect the middle-aged and the elderly, glaucoma can affect people of all ages.
Three days of events uniting research, industry, and philanthropy to prevent vision loss from glaucoma and speed the cure.
Launched in 2007, this annual benefit showcases the visionaries and catalysts who share Glaucoma Research Foundation's mission to cure glaucoma and restore vision through innovative research.
What is Normal-tension glaucoma? Also called low-tension or normal-pressure glaucoma, normal-tension glaucoma (NTG) is a condition in which the optic nerve is damaged without eye pressure exceeding the average range (usually between 12-21mm Hg).
What is Normal-tension glaucoma? Also called low-tension or normal-pressure glaucoma, normal-tension glaucoma (NTG) is a condition in which the optic nerve is damaged without eye pressure exceeding the average range (usually between 12-21mm Hg).
Currently, all therapy for glaucoma is directed at lowering eye pressure, but the fundamental problem in glaucoma is the degeneration of the optic nerve fibers necessary for vision.
glaucoma does affect reading. Why? First, while glaucoma does affect peripheral vision, it also affects central vision. Glaucoma patients with moderate or severe disease often describe looking through a fog which extends into their central vision.
Glaucoma is a disease where the optic nerve gets damaged and the main risk factor is elevated eye pressure (also called intraocular pressure, IOP). The only treatment is to lower the IOP.
Glaucoma Research Foundation (GRF) is pleased to announce the addition of Meredith L. Gale as the organization's new Director of Development. Meredith joins the GRF team to manage donor stewardship programs as well as major and planned giving strategies. Additionally, she will coordinate the GRF Ambassadors program, a national leadership group of glaucoma doctors dedicated to improving access to patient education.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right